Class 4 Medicines Defect Notification: Star Pharmaceuticals Ltd, Enalapril Maleate/ Hydrochlorothiazide 20 Mg/12.5 Mg Tablets, El(26)a/48

Recalling firm
Star Pharmaceuticals Ltd
Reason
Star Pharmaceuticals Limited have informed the MHRA of a typographical error on the strength of hydrochlorothiazide printed on the front face of the carton which incorrectly states “12. mg” instead of “12.5 mg”.
Classification
Class III
Category
drug recall
Country
United Kingdom
Agency
UK Medicines and Healthcare products Regulatory Agency
Recall date
2026-11-12
Status
Ongoing
Distribution
United Kingdom

Official recall notice from UK Medicines and Healthcare products Regulatory Agency

Recall details on Nibble Recalls: https://trynibble.app/recalls/7b0f7338-b1b4-4cc7-9d2e-300f09c2b7ba